Effect of combined probiotic and vitamin D supplementation in the treatment of polycystic ovary syndrome

Phase 3

• Conditions: Polycystic ovary syndrome.; Polycystic ovarian syndrome; E28.2

• Registration Number: IRCT20170513033941N37
• Lead Sponsor: ational Institute for Medical Research Development of Iran (NIMAD)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Patients with polycystic ovary syndrome
Individuals aged 18 to 40 years.

Exclusion Criteria

Pregnant women
Lactation
Adrenal hyperplasia
Androgen-secreting tumors
Hyperprolactinemia
Thyroid dysfunction
Diabetes
Psychological or psychiatric disorders such as anxiety or depressive symptoms at the enrollment

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total testosterone. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Elisa kit.